文献速递流行病学与生物统计组学、生物样本库与精准医学

致新生儿感染的碳青霉烯耐药肺炎克雷伯菌的患病率与克隆多样性:30个国家128篇文献的系统综述

Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: A systematic review of 128 articles across 30 countries.
PubMed 文献 · PLoS Med · 2023-06-20

该研究系统检索多个数据库至2022年6月30日,纳入128项研究、覆盖30个国家127583名新生儿,估算住院新生儿碳青霉烯耐药肺炎克雷伯菌(CRKP)感染合并全球患病率为0.3%(95%CI 0.2%–0.3%),合并死亡率为22.9%(95%CI 13.0%–32.9%)。基因组分析发现146个序列型,ST17在4大洲8国新生儿中出现,NDM是最常见碳青霉烯酶(64.3%)。

要点

  • 住院新生儿CRKP感染合并全球患病率为0.3%(95%CI 0.2%–0.3%)。
  • 新生儿CRKP感染合并死亡率为22.9%(95%CI 13.0%–32.9%)。
  • NDM为最常见碳青霉烯酶(64.3%),ST17在4大洲8国新生儿中出现。

核心结论

  • CRKP在新生儿感染中占相当数量并导致显著新生儿死亡。
  • 新生儿CRKP菌株高度多样,ST17呈全球流行,值得早期检测以用于治疗和预防。
  • blaNDM碳青霉烯酶基因占主导,对新生儿治疗选择构成挑战,并支持继续开展抑制剂相关药物研发。

研究设计与样本

  • 系统综述结合基于基因组的分析,检索PubMed、Web of Science、Embase、Ovid MEDLINE、Cochrane、bioRxiv和medRxiv至2022年6月30日。
  • 纳入128项研究(无预印本),覆盖30个国家(含21个中低收入国家)共127583名新生儿。
  • 采用叙述性综合,使用JMP统计软件合并数据。
  • 从GenBank(含Sequence Read Archive)获得535株新生儿CRKP基因组,其中204株未关联任何发表文献。
  • 将204株基因组结合文献综述分析物种分布、克隆多样性和碳青霉烯酶类型。

主要发现

  • 住院新生儿CRKP感染合并全球患病率为0.3%(95%CI 0.2%–0.3%)。
  • 基于21项报告患者结局的研究,新生儿CRKP感染合并死亡率为22.9%(95%CI 13.0%–32.9%)。
  • 血流感染是报告数据中最常见的感染类型。
  • 鉴定出146个序列型(ST),ST17、ST11和ST15为最常见的3个谱系。
  • ST17 CRKP已在4大洲8国新生儿中出现;可分析碳青霉烯酶的1592株新生儿CRKP菌株中75.3%携带金属β-内酰胺酶基因,NDM为最常见碳青霉烯酶(64.3%)。

局限性

  • 本研究的主要局限是北美、南美和大洋洲数据缺乏或稀少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Klebsiella pneumoniae is the most common pathogen causing neonatal infections, leading to high mortality worldwide. Along with increasing antimicrobial use in neonates, carbapenem-resistant K. pneumoniae (CRKP) has emerged as a severe challenge for infection control and treatment. However, no comprehensive systematic review is available to describe the global epidemiology of neonatal CRKP infections. We therefore performed a systematic review of available data worldwide and combined a genome-based analysis to address the prevalence, clonal diversity, and carbapenem resistance genes of CRKP causing neonatal infections. METHODS AND FINDINGS: We performed a systematic review of studies reporting population-based neonatal infections caused by CRKP in combination with a genome-based analysis of all publicly available CRKP genomes with neonatal origins. We searched multiple databases (PubMed, Web of Science, Embase, Ovid MEDLINE, Cochrane, bioRxiv, and medRxiv) to identify studies that have reported data of neonatal CRKP infections up to June 30, 2022. We included studies addressing the prevalence of CRKP infections and colonization in neonates but excluded studies lacking the numbers of neonates, the geographical location, or independent data on Klebsiella or CRKP isolates. We used narrative synthesis for pooling data with JMP statistical software. We identified 8,558 articles and excluding those that did not meet inclusion criteria. We included 128 studies, none of which were preprints, comprising 127,583 neonates in 30 countries including 21 low- and middle-income countries (LMICs) for analysis. We found that bloodstream infection is the most common infection type in reported data. We estimated that the pooled global prevalence of CRKP infections in hospitalized neonates was 0.3% (95% confidence interval [CI], 0.2% to 0.3%). Based on 21 studies reporting patient outcomes, we found that the pooled mortality of neonatal CRKP infections was 22.9% (95% CI, 13.0% to 32.9%). A total of 535 neonatal CRKP genomes were identified from GenBank including Sequence Read Archive, of which 204 were not linked to any publications. We incorporated the 204 genomes with a literature review for understanding the species distribution, clonal diversity, and carbapenemase types. We identified 146 sequence types (STs) for neonatal CRKP strains and found that ST17, ST11, and ST15 were the 3 most common lineages. In particular, ST17 CRKP has been seen in neonates in 8 countries across 4 continents. The vast majority (75.3%) of the 1,592 neonatal CRKP strains available for analyzing carbapenemase have genes encoding metallo-β-lactamases and NDM (New Delhi metallo-β-lactamase) appeared to be the most common carbapenemase (64.3%). The main limitation of this study is the absence or scarcity of data from North America, South America, and Oceania. CONCLUSIONS: CRKP contributes to a considerable number of neonatal infections and leads to significant neonatal mortality. Neonatal CRKP strains are highly diverse, while ST17 is globally prevalent and merits early detection for treatment and prevention. The dominance of blaNDM carbapenemase genes imposes challenges on therapeutic options in neonates and supports the continued inhibitor-related drug discovery.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Hu Y, Yang Y, Feng Y, et al. Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: A systematic review of 128 articles across 30 countries. PLoS Med. 2023. PMID: 37339120. doi:10.1371/journal.pmed.1004233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。